North America Dog Vaccines Market Size & Outlook
North America dog vaccines market, 2018-2030 (US$M)
Related Markets
North America dog vaccines market highlights
- The North America dog vaccines market generated a revenue of USD 670.0 million in 2023.
- The market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, modified/attenuated live was the largest revenue generating vaccine type in 2023.
- Inactivated (Killed) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 670.0 million |
| Market revenue in 2030 | USD 980.4 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Modified/attenuated live |
| Fastest growing segment | Inactivated (Killed) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/Attenuated Live, Inactivated (Killed) |
| Key market players worldwide | Boehringer Ingelheim, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, Zoetis Inc Class A, Bioveta, Hester Biosciences, Brilliant Bio Pharma, HESKA, Zendal |
Other key industry trends
- In terms of revenue, North America region accounted for 38.6% of the global dog vaccines market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 549.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dog Vaccines Market Scope
Dog Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America dog vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dog vaccines market will help companies and investors design strategic landscapes.
Modified/attenuated live was the largest segment with a revenue share of 52.27% in 2023. Horizon Databook has segmented the North America dog vaccines market based on modified/attenuated live, inactivated (killed) covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Dog Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
- Others
- Modified/Attenuated Live
- Inactivated (Killed)
- North America Dog Vaccines Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Canine Distemper
- Canine Infectious Respiratory Disease Complex (CIRDC)
- Canine Parvovirosis/ Parvovirus Disease
- Canine Leptospirosis
- Canine Lyme Disease
- Infectious Canine Hepatitis
- Canine Rabies
- Other Diseases
- Feline Leukemia
- Feline Panleukopenia (Feline Distemper)
- Feline Respiratory Diseases
- Feline Rabies
- North America Dog Vaccines Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Injectables
- Intranasal
- Oral
- North America Dog Vaccines Duration of immunity Outlook (Revenue, USD Million, 2018-2030)
- 1 Year
- 3 Year
- Others
- North America Dog Vaccines Component Outlook (Revenue, USD Million, 2018-2030)
- Combined Vaccines
- Mono Vaccines
Reasons to subscribe to North America dog vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America dog vaccines market databook
-
Our clientele includes a mix of dog vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dog vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into North America dog vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America dog vaccines market
North America Dog Vaccines Market Outlook Share, 2023 & 2030 (US$M)
North America dog vaccines market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
